The Lacrimal Functional Unit and Why It Matters in oGVHD
The eye maintains comfort and clarity through a coordinated biological system. One useful way to understand this system is the lacrimal functional unit.
The lacrimal functional unit includes the lacrimal glands, ocular surface, eyelids, meibomian glands, conjunctival goblet cells, sensory nerves, and neural reflex pathways that help regulate tearing and blinking. These structures work together to maintain tear-film stability, protect the cornea, support vision, and respond to environmental stress.
In oGVHD, this unit can be disrupted at several points. The lacrimal gland may become inflamed or fibrotic, reducing aqueous tear production. The conjunctiva may become inflamed, scarred, or depleted of goblet cell support. The meibomian glands may contribute less effective lipid to the tear film. The eyelids may become inflamed or structurally altered. The corneal surface may become damaged. Sensory nerves may contribute to symptoms that do not always match visible signs.
This systems view is important because oGVHD is rarely just one failure. A patient may have low tear production, unstable tear film, surface inflammation, eyelid disease, and corneal staining at the same time. These problems can reinforce one another. Poor tear support increases friction. Friction worsens epithelial stress. Epithelial stress increases discomfort. Inflammation may impair healing. The cycle can persist.
The lacrimal functional unit also helps explain why oGVHD can feel different from patient to patient. One person may be dominated by aqueous deficiency. Another may have more evaporative stress. Another may have prominent corneal pain or light sensitivity. Another may show conjunctival scarring. The same diagnostic label can include different biological patterns.
This has implications for clinical care and research. Asking whether the eye is dry is not enough. Better questions include: Is tear production impaired? Is the tear film unstable? Are the eyelids contributing? Is there conjunctival fibrosis? Is the corneal epithelium damaged? Are symptoms suggesting altered nerve function? How much does the disease affect function?
The concept also helps explain why treatment burden can become high. If multiple parts of the ocular surface system are impaired, patients may be asked to use multiple approaches. That burden should be considered part of the disease experience.
For educated patients and advocates, the lacrimal functional unit provides a more accurate vocabulary. oGVHD is not only the absence of tears. It is the breakdown of a protective ocular surface network.
For researchers, that means progress may depend on studying mechanisms, not just symptoms. oGVHD demands a systems-level approach.
This article is for educational purposes only and is not medical advice.
Sources:
- Craig JP, Nichols KK, Akpek EK, et al. “TFOS DEWS II Definition and Classification Report.” The Ocular Surface, 2017.
https://www.tfosdewsreport.org/report-definition_and_classification/48_36/en/ - Tappeiner C, Heiligenhaus A, Halter JP, et al. “Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease.” Frontiers in Medicine, 2023.
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1133381/full - Inamoto Y, Valdés-Sanz N, Ogawa Y, et al. “Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation.” Biology of Blood and Marrow Transplantation, 2019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6362842/
